Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Mixed dyslipoproteinemias: new therapeutic opportunities].

Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna - 1 Oct 1995

Capurso A

Abstract excerpt

Familial combined hyperlipoproteinemia (FCHL) is a dyslipidemic syndrome prevalent in patients with coronary artery disease and characterized by variable expression of hypercholesterolemia, hypertriglyceridemia in a given family, with either or both present in affected individuals. Efforts to refine the phenotype of FCHL have led to the observation that elevated levels of apolipoprotein (apo) B are commonly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hyperlipoproteinemias
Share to Hypolipidemic Agents
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8562265

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Mixed dyslipoproteinemias: new therapeutic opportunities].PMID 8562265Read ↗

Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategiesSemantic proximity Read ↗

[Familial combined hyperlipidemia].Semantic proximity Read ↗

Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E.Semantic proximity Read ↗

Combined hyperlipidemia: familial but not (usually) monogenic.Semantic proximity Read ↗

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.Semantic proximity Read ↗

Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management.Semantic proximity Read ↗

Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.Semantic proximity Read ↗

Genetic dissection of familial combined hyperlipidemia.Semantic proximity Read ↗

[Hypercholesterolemia ].Semantic proximity Read ↗

Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.Semantic proximity Read ↗

[Familial lipoprotein lipase deficiency].Semantic proximity Read ↗

[Familial lipoprotein lipase deficiency].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.